- Health plan considerations for growing direct-to-consumer genetic testing
By Barbara Culley | 17 August 2017
This white paper looks at the progression of direct-to-consumer genetic testing and the current demand and growth, discusses industry concerns, and suggests activities for health plans to consider.
- 2017 U.S. organ and tissue transplant cost estimates and discussion
By T. Scott Bentley, Steve Phillips | 03 August 2017
This report is Milliman’s triennial summary of estimated U.S. average costs per member per month, billed charges, and utilization related to the 30 days prior and 180 days after transplant admission for organ and tissue transplants.
- A valuable proposition: A look into the international private medical insurance market
By Joanne Buckle, Neha Taneja | 13 July 2017
A look at the current global market spread and size of the international private medical insurance (IPMI) market and discussion of some of the key considerations for pricing and experience rating a group IPMI policy.
- 2016 employer stop-loss market: A Milliman survey
By Mehb Khoja, Joy Qin | 05 July 2017
This survey analyzes the differences between health plan and third-party stop-loss carriers and covers product, underwriting, sales/distribution, plan performance, and various other factors.
- Introducing the SSIP: Provisions for market stabilization in the Better Care Reconciliation Act
By Thomas D. Murawski | 28 June 2017
This paper discusses elements of the State Stability and Innovation Program and outlines the details from the draft bill released on June 22.
- The old and the beautiful: How age and gender affect costs and premiums in commercial health care
By Doug Norris, Hans K. Leida, Erica Rode, Travis J. Gray | 08 June 2017
Age/gender rating is an area in which actuarial considerations are often in direct tension with social or public policy considerations.
- Reinsurance and high-risk pools: Past, present, and future role in the individual health insurance market
By Fritz Busch, Paul R. Houchens | 06 June 2017
This paper examines the historical uses of high-risk pools (HRPs) prior to the implementation of the Patient Protection and Affordable Care Act (ACA), the role of reinsurance under the ACA, the proposed usage of reinsurance and HRPs under the American Health Care Act, and considerations for states examining the creation and deployment of these types of mechanisms.
- 2017 Milliman Medical Index
By Christopher S. Girod, Susan K. Hart, Scott A. Weltz | 16 May 2017
In 2017, the cost of healthcare for a typical American family of four covered by an average employer-sponsored preferred provider organization plan is $26,944, according to the Milliman Medical Index.
- Milliman RBRVS for Hospitals
By William J. Fox, Edward Jhu, Charlie Mills, Kevin Frodsham | 27 April 2017
The Milliman RBRVS for Hospitals™ Fee Schedule provides a simple solution for comparing hospital contractual allowed amounts, billed charge master levels, relative efficiency, and patient mix differences.
- Provider price transparency
By Shyam Kolli | 21 March 2017
This paper explores what price transparency means in the healthcare market, the forces driving the need for price transparency, challenges and uses of price transparency, and potential ways in which transparency can be improved for the benefit of consumers and also to be more effective in reducing overall healthcare costs.